WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to aContinue Reading

TUESDAY, Sept. 27, 2022 (HealthDay News) — Adults with hearing loss soon will be able to amble into a big box store or pharmacy — or just visit a website — and buy hearing aids without a prescription. Over-the-counter hearing aids will be on the market by mid-October, available forContinue Reading

WEDNESDAY, Sept. 21, 2022 (HealthDay News) — Too few children with sickle cell anemia are getting the recommended screening tests for stroke, a common complication of this disease, a new government report finds. What’s more, many aren’t receiving hydroxyurea, a medication that can reduce the complications associated with the bloodContinue Reading

TUESDAY, Sept. 20, 2022 (HealthDay News) — The U.S. Food and Drug Administration is warning patients who use a particular insulin pump system that unauthorized people could access it and change how much insulin a patient receives. The pump at the center of the FDA alert is the Medtronic MiniMedContinue Reading

FRIDAY, Sept. 16, 2022 (HealthDay News) — A torn aorta can often be deadly, but a new study has found that survival has improved significantly over the past several decades. But it can still be five times more deadly if not repaired surgically, the researchers added. Aortic dissection happens whenContinue Reading

MONDAY, Sept. 12, 2022 (HealthDay News) — A frequently used screening test for autism creates a gender gap that could hinder diagnosis and treatment for women and girls, a new study suggests. Researchers who study autism have been working to include more women and girls in their studies in recentContinue Reading